Another BET inhibitor, OTX015, is effective against mouse and human MYCN-driven neuroblastoma in models, as it can selectively disrupt the binding of BRD4 and SEs and lead to the repression of MYCN expression95. This evidence concerns the gene MYCN and neuroblastoma.